Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
RTI Health Solutions, Research Triangle Park, NC, USA.
Ther Innov Regul Sci. 2023 Jul;57(4):702-711. doi: 10.1007/s43441-023-00510-8. Epub 2023 Apr 15.
To adapt a patient-reported outcome (PRO) measure, the Western Ontario McMaster Universities Osteoarthritis Index (WOMAC), into efficacy attributes for a discrete choice experiment (DCE) survey designed to quantify the relative importance of endpoints commonly used in knee osteoarthritis (KOA) trials.
The adaptation comprised four steps: (1) selecting domains of interest; (2) determining presentation and framing of selected attributes; (3) determining attribute levels; and (4) developing choice tasks. This process involved input from multiple stakeholders, including regulators, health preference researchers, and patients. Pretesting was conducted to evaluate if patients comprehended the adapted survey attributes and could make trade-offs among them.
The WOMAC pain and function domains were selected for adaption to two efficacy attributes. Two versions of the discrete choice experiment (DCE) instrument were created to compare efficacy using (1) total domain scores and (2) item scores for "walking on a flat surface." Both attributes were presented as improvement from baseline scores by levels of 0%, 30%, 50%, and 100%. Twenty-six participants were interviewed in a pretest of the instrument (average age 60 years; 58% female; 62% had KOA for ≥ 5 years). The participants found both versions of attributes meaningful and relevant for treatment decision-making. They demonstrated willingness and ability to tradeoff improvements in pain and function separately, though many perceived them as inter-related.
This study adds to the growing literature regarding adapting PRO measures for patient preference studies. Such adaptation is important for designing a preference study that can incorporate a clinical trial's outcomes with PRO endpoints.
将患者报告结局(PRO)测量工具——西部安大略省麦克马斯特大学骨关节炎指数(WOMAC)改编为离散选择实验(DCE)调查的疗效属性,旨在量化常用于膝关节骨关节炎(KOA)试验的终点的相对重要性。
改编包括四个步骤:(1)选择感兴趣的领域;(2)确定选定属性的呈现和框架;(3)确定属性水平;(4)开发选择任务。这一过程涉及多个利益相关者的投入,包括监管机构、健康偏好研究人员和患者。进行了预测试,以评估患者是否理解改编后的调查属性并能够在这些属性之间进行权衡。
WOMAC 疼痛和功能领域被选中进行改编,以适应两个疗效属性。创建了两种离散选择实验(DCE)工具版本,以比较(1)总领域评分和(2)“在平坦表面上行走”的项目评分的疗效。这两个属性都以从基线评分提高的水平(0%、30%、50%和 100%)呈现。在仪器的预测试中,对 26 名参与者进行了访谈(平均年龄 60 岁;58%为女性;62%的人患有 KOA 超过 5 年)。参与者认为这两种版本的属性都有意义,并且与治疗决策相关。他们表现出愿意并能够分别权衡疼痛和功能的改善,尽管许多人认为它们是相互关联的。
本研究增加了关于改编 PRO 测量工具用于患者偏好研究的不断增长的文献。这种改编对于设计可以将临床试验结果与 PRO 终点相结合的偏好研究很重要。